Based on these observations, the vWF/ADAMTS13 imbalance has been proposed to be causally related both to the prothrombotic tendency and to the microvascular pulmonary thrombosis, which subtend to a form of thrombotic microangiopathy (TMA) observed in severe COVID-19 patients. Here, VWF is linked to Genetic thrombotic microangiopathy.